Samantha L. Cohen, Marom Bikson, Bashar W. Badran, Mark S. George: A visual and narrative timeline of US FDA milestones for Transcranial Magnetic Stimulation (TMS) devices. In: Brain Stimulation. Band15, Nr.1, Januar 2022, S.73–75, doi:10.1016/j.brs.2021.11.010, PMID 34775141, PMC 8864803 (freier Volltext) – (elsevier.com [abgerufen am 25. April 2025]).
Johan Saelens, Anna Gramser, Victoria Watzal, Carlos A. Zarate, Rupert Lanzenberger, Christoph Kraus: Relative effectiveness of antidepressant treatments in treatment-resistant depression: a systematic review and network meta-analysis of randomized controlled trials. In: Neuropsychopharmacology. 30. Dezember 2024, ISSN1740-634X, S.1–7, doi:10.1038/s41386-024-02044-5 (nature.com [abgerufen am 25. April 2025]).
Daniel M Blumberger, Fidel Vila-Rodriguez, Kevin E Thorpe, Kfir Feffer, Yoshihiro Noda, Peter Giacobbe, Yuliya Knyahnytska, Sidney H Kennedy, Raymond W Lam, Zafiris J Daskalakis, Jonathan Downar: Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. In: The Lancet. Band391, Nr.10131, April 2018, S.1683–1692, doi:10.1016/S0140-6736(18)30295-2 (elsevier.com [abgerufen am 25. April 2025]).
Simone Rossi, Andrea Antal, Sven Bestmann, Marom Bikson, Carmen Brewer, Jürgen Brockmöller, Linda L. Carpenter, Massimo Cincotta, Robert Chen, Jeff D. Daskalakis, Vincenzo Di Lazzaro, Michael D. Fox, Mark S. George, Donald Gilbert, Vasilios K. Kimiskidis, Giacomo Koch, Risto J. Ilmoniemi, Jean Pascal Lefaucheur, Letizia Leocani, Sarah H. Lisanby, Carlo Miniussi, Frank Padberg, Alvaro Pascual-Leone, Walter Paulus, Angel V. Peterchev, Angelo Quartarone, Alexander Rotenberg, John Rothwell, Paolo M. Rossini, Emiliano Santarnecchi, Mouhsin M. Shafi, Hartwig R. Siebner, Yoshikatzu Ugawa, Eric M. Wassermann, Abraham Zangen, Ulf Ziemann, Mark Hallett: Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines. In: Clinical Neurophysiology. Band132, Nr.1, Januar 2021, S.269–306, doi:10.1016/j.clinph.2020.10.003, PMID 33243615, PMC 9094636 (freier Volltext) – (elsevier.com [abgerufen am 25. April 2025]).
elsevier.com
linkinghub.elsevier.com
Samantha L. Cohen, Marom Bikson, Bashar W. Badran, Mark S. George: A visual and narrative timeline of US FDA milestones for Transcranial Magnetic Stimulation (TMS) devices. In: Brain Stimulation. Band15, Nr.1, Januar 2022, S.73–75, doi:10.1016/j.brs.2021.11.010, PMID 34775141, PMC 8864803 (freier Volltext) – (elsevier.com [abgerufen am 25. April 2025]).
Daniel M Blumberger, Fidel Vila-Rodriguez, Kevin E Thorpe, Kfir Feffer, Yoshihiro Noda, Peter Giacobbe, Yuliya Knyahnytska, Sidney H Kennedy, Raymond W Lam, Zafiris J Daskalakis, Jonathan Downar: Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. In: The Lancet. Band391, Nr.10131, April 2018, S.1683–1692, doi:10.1016/S0140-6736(18)30295-2 (elsevier.com [abgerufen am 25. April 2025]).
Simone Rossi, Andrea Antal, Sven Bestmann, Marom Bikson, Carmen Brewer, Jürgen Brockmöller, Linda L. Carpenter, Massimo Cincotta, Robert Chen, Jeff D. Daskalakis, Vincenzo Di Lazzaro, Michael D. Fox, Mark S. George, Donald Gilbert, Vasilios K. Kimiskidis, Giacomo Koch, Risto J. Ilmoniemi, Jean Pascal Lefaucheur, Letizia Leocani, Sarah H. Lisanby, Carlo Miniussi, Frank Padberg, Alvaro Pascual-Leone, Walter Paulus, Angel V. Peterchev, Angelo Quartarone, Alexander Rotenberg, John Rothwell, Paolo M. Rossini, Emiliano Santarnecchi, Mouhsin M. Shafi, Hartwig R. Siebner, Yoshikatzu Ugawa, Eric M. Wassermann, Abraham Zangen, Ulf Ziemann, Mark Hallett: Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines. In: Clinical Neurophysiology. Band132, Nr.1, Januar 2021, S.269–306, doi:10.1016/j.clinph.2020.10.003, PMID 33243615, PMC 9094636 (freier Volltext) – (elsevier.com [abgerufen am 25. April 2025]).
nature.com
Johan Saelens, Anna Gramser, Victoria Watzal, Carlos A. Zarate, Rupert Lanzenberger, Christoph Kraus: Relative effectiveness of antidepressant treatments in treatment-resistant depression: a systematic review and network meta-analysis of randomized controlled trials. In: Neuropsychopharmacology. 30. Dezember 2024, ISSN1740-634X, S.1–7, doi:10.1038/s41386-024-02044-5 (nature.com [abgerufen am 25. April 2025]).
nih.gov
ncbi.nlm.nih.gov
Samantha L. Cohen, Marom Bikson, Bashar W. Badran, Mark S. George: A visual and narrative timeline of US FDA milestones for Transcranial Magnetic Stimulation (TMS) devices. In: Brain Stimulation. Band15, Nr.1, Januar 2022, S.73–75, doi:10.1016/j.brs.2021.11.010, PMID 34775141, PMC 8864803 (freier Volltext) – (elsevier.com [abgerufen am 25. April 2025]).
Simone Rossi, Andrea Antal, Sven Bestmann, Marom Bikson, Carmen Brewer, Jürgen Brockmöller, Linda L. Carpenter, Massimo Cincotta, Robert Chen, Jeff D. Daskalakis, Vincenzo Di Lazzaro, Michael D. Fox, Mark S. George, Donald Gilbert, Vasilios K. Kimiskidis, Giacomo Koch, Risto J. Ilmoniemi, Jean Pascal Lefaucheur, Letizia Leocani, Sarah H. Lisanby, Carlo Miniussi, Frank Padberg, Alvaro Pascual-Leone, Walter Paulus, Angel V. Peterchev, Angelo Quartarone, Alexander Rotenberg, John Rothwell, Paolo M. Rossini, Emiliano Santarnecchi, Mouhsin M. Shafi, Hartwig R. Siebner, Yoshikatzu Ugawa, Eric M. Wassermann, Abraham Zangen, Ulf Ziemann, Mark Hallett: Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines. In: Clinical Neurophysiology. Band132, Nr.1, Januar 2021, S.269–306, doi:10.1016/j.clinph.2020.10.003, PMID 33243615, PMC 9094636 (freier Volltext) – (elsevier.com [abgerufen am 25. April 2025]).
zdb-katalog.de
Johan Saelens, Anna Gramser, Victoria Watzal, Carlos A. Zarate, Rupert Lanzenberger, Christoph Kraus: Relative effectiveness of antidepressant treatments in treatment-resistant depression: a systematic review and network meta-analysis of randomized controlled trials. In: Neuropsychopharmacology. 30. Dezember 2024, ISSN1740-634X, S.1–7, doi:10.1038/s41386-024-02044-5 (nature.com [abgerufen am 25. April 2025]).
